Pharmacogenomics and end-organ susceptibility to injury in the perioperative period

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 1, 2008, Pages 23-37

  Schwinn, Debra A ^a   Podgoreanu, Mihai ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adverse event; anesthesiology; genetic; genomic; human; intensive care; outcome; prediction; surgery

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; FALSE POSITIVE RESULT; GENETIC ANALYSIS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLYCEMIC CONTROL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; LINKAGE ANALYSIS; METABOLOMICS; MICROARRAY ANALYSIS; NONHUMAN; PERIOPERATIVE PERIOD; PHARMACOGENOMICS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANESTHESIA; GENOMICS; HUMANS; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VARIATION (GENETICS);

EID: 41049107831     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2007.09.005     Document Type: Review

References (100)

1. Kozak L.J., Owings M.F., and Hall M.J. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital and Health Statistics 13 158 (2005 Mar) 1-199
2. Podgoreanu M.V., and Schwinn D.A. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. Journal of the American College of Cardiology 46 11 (2005 Dec 6) 1965-1977
3. Podgoreanu M.V., White W.D., Morris R.W., et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction following cardiac surgery. Circulation 114 (2006) 275-281
4. Newby L.K., Alpert J.S., Ohman E.M., et al. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. American Heart Journal 144 (2002) 957-980
5. Ishii Y., Schuessler R.B., Gaynor S.L., et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 111 (2005) 2881-2888
6. Mielck F., Ziarkowski A., Hanekop G., et al. Cerebral inflammatory response during and after cardiac surgery. European Journal of Anaesthesiology 22 5 (2005 May) 347-352
7. Maggio M., Ceda B.P., De Cicco G., et al. Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting. Journal of Endocrinological Investigation 28 (2005) 711-719
8. Chang A. Inflammatory mediators in children undergoing cardiopulmonary bypass: is there a unified field theory amidst this biomolecular chaos?. Pediatric Critical Care Medicine 4 (2003) 386-387
9. Krinsley J. Perioperative glucose control. Current Opinion in Anaesthesiology 19 (2006) 111-116
10. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings 80 7 (2005 Jul) 862-866
11. Pittas A.G., Siegel R.D., and Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN. Journal of Parenteral and Enteral Nutrition 30 (2006) 164-172
12. Devaraj S., Venugopal S.K., Singh U., and Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-{alpha} and -{beta}. Diabetes 54 1 (2005 January 1) 85-91
13. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiological Reviews 86 (2006) 465-514
14. Scirica B.M., and Morrow D.A. Is C-reactive protein an innocent bystander or proatherogenic culprit?. Circulation 113 (2006) 2128-2151
15. van Acker B.A., Hulsewe K.W., Wagenmakers A.J., et al. Glatamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. The Journal of Nutrition (2000) 1566-1571
16. Botfield C., Ross R.J., and Hinds C.J. The role of IGFs in catabolism. Baillieres Clinical Endocrinology and Metabolism 11 (1997) 679-697
17. Tjader I., Essen P., Thorne A., et al. Muscle protein synthesis rate decreases 24hrs after abdominal surgery irrespective of total parenteral nutrition. JPEN. Journal of Parenteral and Enteral Nutrition 20 (1996) 135-138
18. Heindorff H.A. The hepatic catabolic stress response: hormonal regulation of urea synthesis after surgery. Danish Medical Bulletin 40 (1993) 224-234
19. Ikonomidis I., Athanassopoulos G., Lekakis J., et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation 112 (2005) 3272-3279
20. Mao W., Iwai C., Keng P.C., et al. Norepinephrine-induced oxidative stress causes PC-12 cell apoptosis by both endoplasmic reticulum stress and mitochondrial intrinsic pathway: inhibition of phosphatidylinositol 3-kinase survival pathway. American Journal of Physiology. Cell Physiology 290 (2006) C1373-C1384
21. Dennis S.C., Gevers W., and Opie L.H. Protons in ischemia: where do they come from; where do they go to?. Journal of Molecular and Cellular Cardiology 23 (1991) 1077-1086
22. Ockaili R., Natarajan R., Salloum F., et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American Journal of Physiology. Heart and Circulatory Physiology 289 (2005) H542-H548
23. Tsang A., Hausenloy D.J., and Yellon D.M. Myocardial postconditioning: reperfusion injury revisited. American Journal of Physiology. Heart and Circulatory Physiology 289 (2005) H2-H7
24. Kutala V.K., Khan M., Mandal R., et al. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. The Journal of Pharmacology and Experimental Therapeutics 317 (2006) 921-928
25. Churchill E.N., Murriel C.L., Chen C.-H., et al. Reperfusion-induced translocation of delta PKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circulation Research 97 (2005) 78-85
26. van Empel V.P.M., Bertrand A.T., van der Nagel R., et al. Downregulation of apoptosis-inducing factor in Harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circulation Research 96 (2005) E92-E101
27. Rui T., and Kvietys P.R. NFkB and AP-1 differentially contribute to the induction of Mn-SOD and eNOS during the development of oxidant tolerance. FASEB Journal 19 (2005) 1908-1910
28. Chong A.J., Pohlman T.H., Hampton C.R., et al. Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury. Annals of Thoracic Surgery 75 2 (2003 Feb) S649-S655
29. BelAiba R.S., Djordjevic T., Bonello S., et al. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circulation Research 98 (2006) 828-836
30. Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Annals of Thoracic Surgery 75 2 (2003 Feb) S715-S720
31. Rinder C.S., Mathew J.P., Rinder H.M., et al. Platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass. Anesthesiology 97 5 (2002 Nov) 1118-1122
32. Nadra I., Mason J.C., Philippidis P., et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification. Circulation Research 96 (2005) 1248-1256
33. Goldstein J.I., Goldstein K.A., Wardwell K., et al. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. Atherosclerosis 170 (2003) 325-332
34. Christenson R.H., deFilippi C.P., and Kreutzer D. Biomarkers of ischemia in patients with known coronary artery disease: do interleukin-6 and tissue factor measurements during dobutamine stress echocardogarphy give additional insight?. Circulation 112 (2005) 3215-3217
35. Ikonomidis I., Andreotti F., and Nihoyannopoulos P. Reduction of daily-life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. Heart 90 (2004) 389-393
36. Rother R.P., Bell L., Hillmen P., and Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. The Journal of the American Medical Association 293 (2005) 1653-1662
37. Pasceri V., Pristipino C., Pelliccia F., et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. American Journal of Cardiology 95 (2005) 1358-1361
38. Zieker D., Elvira F., Dietzsch J., et al. cDNA microarray analysis reveals novel candidate genes expressed in human peripheral blood following exhaustive exercise. Physiological Genomics 23 (2005) 287-294
39. Hoffman-Goetz L., and Pedersen B.K. Exercise and the immune system: a model of the stress response?. Immunology Today 15 (1994) 382-387
40. Steenberg A., Fischer C.P., Keller C., et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology. Endocrinology and Metabolism 285 (2003) E433-E437
41. Niess A.M., Dickhuth H.H., Northoff H., and Fehrenbach E. Free radicals and oxidative stress in exercise - immulogic aspects. Exercise Immunology Review 5 (1999) 22-56
42. Russell A.P., Hesselink M.K.C., Lo S.K., and Schrauwen P. Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB Journal 19 (2005) 986-988
43. Talwar S., Munson P.J., Barb J., et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiological Genomics 25 (2006) 203-215
44. Calvano S.E., Xiao W., Richards D.R., et al. A network-based analysis of systemic inflammation in humans. Nature 437 (2005) 1032-1037
45. Wada Y., Otu H., Wu S., et al. Preconditioning of primary human endothelial cells with inflammatory mediators alters the "set point" of the cell. FASEB Journal 19 (2005) 1914-1916
46. Fox A.A., Shernan S.K., and Body S.C. Predictive genomics of adverse events after cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia 8 4 (2004 Dec) 297-315
47. Stuber F., and Hoeft A. The influence of genomics on outcome after cardiovascular surgery. Current Opinion in Anaesthesiology 15 (2002) 3-8
48. Ziegeler S., Tsusaki B.E., and Collard C.D. Influence of genotype on perioperative risk and outcome. Anesthesiology 99 1 (2003 Jul) 212-219
49. Donahue B.S., and Balser J.R. Perioperative genomics. Venturing into uncharted seas. Anesthesiology 99 1 (2003 Jul) 7-8
50. Broeckel U., Hengstenberg C., Mayer B., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nature Genetics 30 2 (2002 Feb) 210-214
51. Gretarsdottir S., Sveinbjornsdottir S., Jonsson H.H., et al. Localization of a susceptibility gene for common forms of stroke to 5q12. American Journal of Human Genetics 70 3 (2002 Mar) 593-603
52. Knight J.C. Regulatory polymorphisms underlying complex disease traits. Journal of Molecular Medicine 83 2 (2005 Feb) 97-109
53. Faraday N., Martinez E.A., Scharpf R.B., et al. Platelet gene polymorphisms and cardiac risk assessment in vascular surgical patients. Anesthesiology 101 6 (2004 Dec) 1291-1297
54. Gaudino M., Andreotti F., Zamparelli R., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 supplment 1 (2003 Sep 9) II195-II199
55. Ortlepp J.R., Hoffmann R., Killian A., et al. The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients. Clinical Cardiology 24 9 (2001 Sep) 585-591
56. Holweg C.T., Weimar W., Uitterlinden A.G., and Baan C.C. Clinical impact of cytokine gene polymorphisms in heart and lung transplantation. The Journal of Heart and Lung Transplantation 23 9 (2004 Sep) 1017-1026
57. MacKensen G.B., Swaminathan M., Ti L.K., et al. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Annals of Thoracic Surgery 78 2 (2004 Aug) 520-526
58. Stafford-Smith M., Podgoreanu M., Swaminathan M., et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. American Journal of Kidney Diseases 45 3 (2005 Mar) 519-530
59. Mathew J.P., Rinder C.S., Howe J.G., et al. Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Annals of Thoracic Surgery 71 2 (2001 Feb) 663-666
60. Tardiff B.E., Newman M.F., Saunders A.M., et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Annals of Thoracic Surgery 64 3 (1997 Sep) 715-720
61. Grocott H.P., White W.D., Morris R.W., et al. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke (2005 Jul 28)
62. Zotz R.B., Klein M., Dauben H.P., et al. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thrombosis and Haemostasis 83 3 (2000 Mar) 404-407
63. Welsby I.J., Podgoreanu M.V., Phillips-Bute B., et al. Genetic factors contribute to bleeding after cardiac surgery. Journal of Thrombosis and Haemostasis 3 6 (2005 Jun) 1206-1212
64. Donahue B.S., Gailani D., Higgins M.S., et al. Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation 107 7 (2003 Feb 25) 1003-1008
65. Moretti E.W., Morris R.W., Podgoreanu M., et al. APOE polymorphism is associated with risk of severe sepsis in surgical patients. Critical Care Medicine 33 (2005) 2521-2526
66. Stuber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Critical Care Medicine 24 3 (1996 Mar) 381-384
67. Brull D.J., Montgomery H.E., Sanders J., et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arteriosclerosis Thrombosis and Vascular Biology 21 9 (2001 Sep) 1458-1463
68. Burzotta F., Iacoviello L., Di Castelnuovo A., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. American Journal of Cardiology 88 10 (2001 Nov 15) 1125-1128
69. Grocott H.P., Newman M.F., El-Moalem H., et al. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 122 3 (2001 Sep) 622-623
70. Roth-Isigkeit A., Hasselbach L., Ocklitz E., et al. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clinical and Experimental Immunology 125 1 (2001 Jul) 80-88
71. Galley H.F., Lowe P.R., Carmichael R.L., and Webster N.R. Genotype and interleukin-10 responses after cardiopulmonary bypass. British Journal of Anaesthesia 91 3 (2003 Sep) 424-426
72. Shaw A.D., Vaporciyan A.A., Wu X., et al. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Annals of Thoracic Surgery 79 5 (2005 May) 1704-1710
73. Viant M.R., Rosenblum E.S., and Tieerdema R.S. NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. Environmental Science & Technology 37 21 (2003 Nov 1) 4982-4989
74. Serkova N., Fuller T.F., Klawitter J., et al. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney International 67 3 (2005 Mar) 1142-1151
75. Singleton K.D., Serkova N., Beckey V.E., and Wischmeyer P.E. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Critical Care Medicine 33 6 (2005 Jun) 1206-1213
76. Wischmeyer P.E., Jayakar D., Williams U., et al. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. JPEN. Journal of Parenteral and Enteral Nutrition 27 6 (2003 Nov-Dec) 396-403
77. Sabatine M.S., Emerson L., Morrow D.A., et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112 (2005) 3868-3875
78. Steed L., Kong R., Stygall J., et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Annals of Thoracic Surgery 71 3 (2001 Mar) 823-826
79. Newman M.F., Booth J.V., Laskowitz D.T., et al. Genetic predictors of perioperative neurological and cognitive injury and recovery. Best Practice and Research Clinical Anesthesiology 15 2 (2001) 247-276
80. Podgoreanu M., Lin S., Haystead T., et al. Genomic and proteomic profiling of occluded coronary saphenous vein grafts. Anesthesia & Analgesia 100 (2005) SCA71 (abstr)
81. Podgoreanu M.V., and Schwinn D.A. Genomics and the circulation. British Journal of Anaesthesia 93 1 (2004 Jul) 140-148
82. Borozdenkova S., Smith J., Marshall S., et al. Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation. Human Immunology 62 3 (2001 Mar) 247-255
83. Puthothu B, Krueger M, Bernhardt M & Heinzmann A. ICAM1 amino-acid variant K469E is associated with paediatric bronchial asthma and elevated sICAM1 levels. Genes and Immunity. in press (epub online).
84. Kawamura T., Umemura T., Kanai A., et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism 55 (2006) 461-466
85. Kaplanski G., Marin V., Fabrigoule M., et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 92 (1998) 1259-1267
86. Collins P.W., Noble K.E., Reittie J.R., et al. Induction of tissue factor expression in human monocyte/endothelium cocultures. British Journal of Haematology 91 (1995) 963-970
87. Coughlin S.R. Protease-activated receptors in hemostasis, thrombosis, and vascular biology. Journal of Thrombosis and Haemostasis 3 (2005) 1800-1814
88. Armstrong E.J., Morrow D.A., and Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. Circulation 113 (2006) 152-155
89. Zheng F., Chevalier J.A., Zhang L.Q., et al. An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease. Clinical Genetics 59 (2001) 58-64
90. Ghilardi G., Biondi M.L., Turri O., et al. Ser128Arg gene polymorphism for E-selectin and severity of atherosclerotic arterial disease. The Journal of Cardiovascular Surgery 45 (2004) 143-147
91. Jilma B., Marsik C., Kovar F., et al. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood 105 (2005) 2380-2383
92. Edelstein L.C., Pan A., and Collins T. Chromatin modification and the endothelial-specific activation of the E-selectin gene. The Journal of Biological Chemistry 280 (2005) 11192-11202
93. Joucher F., Mazmanian G.M., and German-Fattal M. E-selectin early overexpression induced by allogeneic activation in isolated mouse lung. Transplantation 78 (2004) 1283-1289
94. Meigs J.B., Hu F.B., Perhanidis J.S., et al. E-selectin genotypes and risk of type 2 diabetes in women. Obesity Research 13 (2005) 1845-1847
95. Yu Y., Moulton K.S., Khan M.K., et al. E-selectin is required for the antiangiogenic activity of endostatin. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 8005-8010
96. Zanardo R.C., Bonder C.S., Hwang J.M., et al. A down-regulatable E-selectin ligand is functionally important for PSGL-1-independent leukocyte-endothelial cell interactions. Blood 104 (2004) 3766-3773
97. Galimberti D., Fenoglio C., Clerici R., et al. E-selectin A561C and G98T polymorphisms influence susceptibilityand course of multiple sclerosis. Journal of Neuroimmunology 165 (2005) 201-205
98. Podgoreanu M.V., Michelotti G.A., Sato Y., et al. Differential cardiac gene expression during cardiopulmonary bypass: ischemia-independent upregulation of proinflammatory genes. The Journal of Thoracic and Cardiovascular Surgery 130 2 (2005 Aug) 330-339
99. Hakonarson H., Thorvaldsson S., Helgadottir A., et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. The Journal of the American Medical Association 293 18 (2005 May 11) 2245-2256
100. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genetics 36 3 (2004 Mar) 233-239